KRMD
KORU Medical Systems, Inc.
Next earnings Aug 10, 2026 (after close) · consensus $-0.02 EPS, $11.8M rev
Last earnings -1.7% on 2026-05-06
$4.46
▲ +4.21%$4.46▲ +31.95%
over 1Y
L $2.94EODHDH $6.52
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.2%
1W+15.5%
1M+7.5%
3M+5.7%
YTD-20.5%
1Y+32.0%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Revenue grew 22.2% YoY; but unprofitable (net margin -6.4%).
KORU Medical Systems, Inc. shows $41.1M in FY2025 revenue (+22.2% YoY), a -6.4% net margin, and -15.5% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $23.5M | $27.9M | $28.5M | $33.6M | $41.1M |
| Gross profit | $13.8M | $15.4M | $16.7M | $21.3M | $25.6M |
| Operating income | -$7.03M | -$10.8M | -$10.3M | -$6.45M | -$2.97M |
| Net income | -$4.56M | -$8.66M | -$13.7M | -$6.07M | -$2.64M |
| Diluted EPS | -$0.10 | -$0.19 | -$0.30 | -$0.13 | -$0.06 |
| Net margin | -19.4% | -31.0% | -48.2% | -18.0% | -6.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$198M
EV / EBITDA—
EV / Sales4.8
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-1.3%
FCF yield-0.2%
Quality & risk
ROIC (est.)-13.5%
Free cash flow-$470K
Total debt$348K
Net cash$8.52M
Altman Z-Score11.15 safe
Piotroski F-Score5/9
Capital returns
Buyback yield0.0%
Dividend yield (est.)—
Shareholder yield0.0%
Shares Δ YoY+0.9%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-06-112026-06-15open ↗8-KPeriod ending 2026-05-192026-05-21open ↗4Period ending 2026-05-182026-05-20open ↗4/APeriod ending 2026-05-152026-05-20open ↗4Period ending 2026-05-152026-05-20open ↗4Period ending 2026-05-142026-05-19open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗144Filing2026-05-14open ↗10-QPeriod ending 2026-03-312026-05-06open ↗
Frequently asked
- Is KORU Medical Systems, Inc. (KRMD) a buy?
- KRMD currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 22.2% YoY; but unprofitable (net margin -6.4%).
- What is KORU Medical Systems, Inc.'s quality score?
- KRMD scores 55.35294117647058/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0000704440, latest 10-Q filed 2026-05-06) · EODHD · as of 6/26/2026, 8:02:57 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.